Authorssort descending Title E-pub date Journal name
Periyasamy M, Patel H, Lai CF, Nguyen VT, Nevedomskaya E, Harrod A, et al. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Ac... Tuesday, September 29, 2015 Cell reports
Permuth-Wey, J., Lawrenson, K., Shen, H. C., Velkova, A., Tyrer, J. P., Che... Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 Nature Communications, 4
Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, et... A glycolytic phenotype is associated with prostate cancer progression and a... Thursday, April 16, 2015 The Journal of pathology
Pertega-Gomes N, Vizcaino JR, Felisbino S, Warren AY, Shaw G, Kay J, et al. Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein ov... Wednesday, June 3, 2015 Oncotarget
Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard ... Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and... Thursday, October 23, 2014 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Peters CJ, Rees JR, Hardwick RH, Hardwick JS, Vowler SL, Ong CA, Zhang C, S... A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia Gastroenterology
Pfister R, Bragelmann J, Michels G, Wareham NJ, Luben R, Khaw KT Performance of the CHARGE-AF risk model for incident atrial fibrillation in... Saturday, July 26, 2014 European journal of preventive cardiology
Pharoah, P. D. P., Tsai, Y. -Y., Ramus, S. J., Phelan, C. M., Goode, E. L.,... GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer Nature Genetics
Philippou Y, Raja H, Gnanapragasam VJ Active surveillance of prostate cancer: a questionnaire survey of urologist... Sunday, June 14, 2015 BMC urology
Phillips, K. A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C.,... Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers J Clin Oncol

Pages